Human VEGF165b synthetic peptide, Accession # AAL27435
Specificity
Detects human VEGF165b in direct ELISAs and Western blots. Recognizes an epitope within a 9 amino acid sequence at the C-terminus of human VEGF165b. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) VEGF206, rhVEGF-B167, rhVEGF-B186, rhVEGF-C, or rhVEGF-D is observed.
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. Small pack size is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.
Application
Western Blot; Immunohistochemistry; Immunofluorescence
At -20°C for one year. After reconstitution , at 4°C for one month. It can also be aliquotted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.6 months, -20 to -70 °C under sterile conditions after reconstitution.
For research or further manufacturing use only. Not for use in humans.
CONTACT US
USA
Europe
ABOUT US
As a pioneer of biotechnology, Creative Bioarray has developed into a leading biotechnology company in the world. We are committed to providing our customers with innovative high-quality products and services through discovering, developing, and manufacturing.